King Luther Capital Management Corp Gilead Sciences, Inc. Transaction History
King Luther Capital Management Corp
- $22.8 Billion
- Q4 2024
A detailed history of King Luther Capital Management Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, King Luther Capital Management Corp holds 8,966 shares of GILD stock, worth $861,004. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,966
Previous 8,903
0.71%
Holding current value
$861,004
Previous $746,000
10.99%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding GILD
# of Institutions
1,990Shares Held
992MCall Options Held
10.5MPut Options Held
9.85M-
Black Rock Inc. New York, NY121MShares$11.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$11.1 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.35 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.93 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.78 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $120B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...